Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
SPECIALTY AND ONCOLOGY
March 14, 2024
Specialty Pharmacy News Digest
November 16, 2023
Tofersen Gains Accelerated Approval for ALS
February 17, 2023
Specialty Pharmacy News Digest
March 15, 2022
Anticipating the First Adalimumab Biosimilar
March 15, 2022
Specialty Pharmacy News Digest
January 14, 2022
Oral Chemotherapeutic Agents and the Role of Specialty Pharmacies
October 15, 2021
Treatment Updates for Metastatic Breast Cancer
October 16, 2020
PARP Inhibitors in Gynecologic Malignancies
September 3, 2020
Supplemental NDA Submitted for Renal Cell Carcinoma Combination Treatment
August 27, 2020
Teriparatide Efficacious for Medication-Related Osteonecrosis of the Mandible
August 27, 2020
FDA Grants Fast Track Status for Enzastaurin
August 12, 2020
Advances in the Management of Sickle Cell Disease
August 12, 2020
Hemophilia Review
Load More
X
April 2024
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image